STASIS Clinical Study Begins in Europe
Top-line Data Expected by Year End
NEWTOWN, Pa., Sept. 9, 2014 /PRNewswire/ – Micro Interventional Devices, Inc. (MID) reports the first successful clinical case using its Permaseal Cardiac Access and Closure technology. This new technology ... READ MORE>>
PLSG portfolio company Complexa has welcomed Francisco D. Salva as the company’s new Chief Executive Officer and President. Complexa is a clinical-stage..
BioAdvance Biotechnology Greenhouse
of Southeastern Pennsylvania
215.966.6214 | bioadvance.com
Life Sciences Greenhouse
of Central Pennsylvania
717.635.2100 | lsgpa.com
Pittsburgh Life Sciences
Greenhouse
412.201.7370 | plsg.com
Recent Posts
READ MORE>>
Source: BioAdvance
READ MORE>>
Source: LSGPA
Complexa Appoints Francisco D. Salva Chief Executive Officer and President
PLSG portfolio company Complexa has welcomed Francisco D. Salva as the company’s new Chief Executive Officer and President. Complexa is a clinical-stage..
1 likes, 0 comments ⋅ 16 hours ago